Identification of therapeutic targets in lung adenocarcinoma using Mendelian randomization and multi-omics
ICAM5 emerges as a promising biological marker with significant prognostic and therapeutic potential in LUAD.
Authors
- Zhuying Li (ORCID: https://orcid.org/0009-0006-9282-2619)
- Keru Ma (ORCID: https://orcid.org/0000-0003-3397-5667)
- Zongying Liu (ORCID: https://orcid.org/0000-0003-3658-3511)
- Yue Li (ORCID: https://orcid.org/0009-0007-9106-8623)
- Hao Wang (ORCID: https://orcid.org/0000-0003-2040-4136)
Institutions
- Harbin Medical University (CN)
- Heilongjiang University of Chinese Medicine (CN)
- First Affiliated Hospital of Heilongjiang University of Chinese Medicine (CN)
- Third Affiliated Hospital of Harbin Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-06-07
- DOI
- https://doi.org/10.1007/s12672-025-02835-2
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00